This site is intended for healthcare professionals only
LoginRegister
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesOdisha Pharma Summit 2025 on December 16; policy launch, parks expected
Over 17000 Jan Aushadhi Kendras opened nationwide till November 30: Minister tells ParliamentOver 17000 Jan Aushadhi Kendras opened nationwide till November 30: Minister tells Parliament
Telangana: Rs 5.82 lakh worth of drugs seized from unlicensed premises at Fertility CentreTelangana: Rs 5.82 lakh worth of drugs seized from unlicensed premises at Fertility Centre
WockhardtWockhardt Gets Expert Panel Nod for Phase III Study of Recombinant Insulin Aspart
Biocon Chief Kiran Mazumdar-Shaw wins USC Business Management AwardBiocon Chief Kiran Mazumdar-Shaw wins USC Business Management Award
CDSCO Panel Seeks Revised Phase IV Study for Zydus Empagliflozin, Metformin FDCCDSCO Panel Seeks Revised Phase IV Study for Zydus' Empagliflozin, Metformin FDC
Corona Remedies Bhayla facility commences additional commercial production of medicinesComplaints on Jan Aushadhi medicines can be filed via CPGRAMS, email or helpline: Minister
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon unveils Liraglutide for diabetes, obesity in Netherlands
Judicious use of AI can be boon for healthcare pharma sectors: Dr Jitendra SinghJudicious use of AI can be boon for healthcare pharma sectors: Dr Jitendra Singh
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics ArmBiocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept...
JnJ bags USFDA nod for Akeega plus prednisone for prostate cancerJnJ bags USFDA nod for Akeega plus prednisone for BRCA2 mutated metastatic castration sensitive...
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indication
X